| Product Code: ETC9682630 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Cyclooxygenase 2 Inhibitor Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Cyclooxygenase 2 Inhibitor Market - Industry Life Cycle |
3.4 Thailand Cyclooxygenase 2 Inhibitor Market - Porter's Five Forces |
3.5 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.7 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Cyclooxygenase 2 Inhibitor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases such as arthritis and osteoarthritis in Thailand |
4.2.2 Growing aging population leading to higher demand for pain management medications |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in Thailand |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and marketing in Thailand |
4.3.2 Presence of alternative pain management therapies impacting the market growth |
4.3.3 Concerns regarding potential side effects and safety of cyclooxygenase 2 inhibitors |
5 Thailand Cyclooxygenase 2 Inhibitor Market Trends |
6 Thailand Cyclooxygenase 2 Inhibitor Market, By Types |
6.1 Thailand Cyclooxygenase 2 Inhibitor Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Celecoxib, 2021- 2031F |
6.1.4 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Rofecoxib, 2021- 2031F |
6.1.5 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Valdecoxib, 2021- 2031F |
6.1.6 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Amlodipine, 2021- 2031F |
6.1.7 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Thailand Cyclooxygenase 2 Inhibitor Market, By Types |
6.2.1 Overview and Analysis |
6.2.2 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Selective cox 2 inhibitor, 2021- 2031F |
6.2.3 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Non-selective cox 2 inhibitor, 2021- 2031F |
6.3 Thailand Cyclooxygenase 2 Inhibitor Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Osteoarthritis, 2021- 2031F |
6.3.3 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Rheumatoid arthritis, 2021- 2031F |
6.3.4 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Thailand Cyclooxygenase 2 Inhibitor Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Thailand Cyclooxygenase 2 Inhibitor Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Thailand Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Cyclooxygenase 2 Inhibitor Market Import-Export Trade Statistics |
7.1 Thailand Cyclooxygenase 2 Inhibitor Market Export to Major Countries |
7.2 Thailand Cyclooxygenase 2 Inhibitor Market Imports from Major Countries |
8 Thailand Cyclooxygenase 2 Inhibitor Market Key Performance Indicators |
8.1 Patient adherence rate to cyclooxygenase 2 inhibitor therapy |
8.2 Number of healthcare facilities offering cyclooxygenase 2 inhibitors |
8.3 Prescription rate of cyclooxygenase 2 inhibitors compared to other pain medications |
9 Thailand Cyclooxygenase 2 Inhibitor Market - Opportunity Assessment |
9.1 Thailand Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Thailand Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Types, 2021 & 2031F |
9.3 Thailand Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Thailand Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Thailand Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Cyclooxygenase 2 Inhibitor Market - Competitive Landscape |
10.1 Thailand Cyclooxygenase 2 Inhibitor Market Revenue Share, By Companies, 2024 |
10.2 Thailand Cyclooxygenase 2 Inhibitor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here